Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL9116

CARACEMIDE
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
CNC(=O)ON(C(C)=O)C(=O)NC

Basic Information

ChEMBL ID CHEMBL9116
Name CARACEMIDE
Phase Phase II
Structure Type MOL
InChI Key JURAJLFHWXNPHG-UHFFFAOYSA-N

Known Names

Caracemida Caracemide NSC-253272
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
6
Publications
3
Known Names

Molecular Properties

189.2
MW (Da)
-0.55
ALogP
4
HBA
2
HBD
87.7
PSA (Ų)
0.50
QED
0
Ro5 Violations
0
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral
USAN Year 1983

Extended Properties

Molecular Formula C6H11N3O4
MW 189.17
Aromatic Rings 0
Heavy Atoms 13
NP-Likeness -0.25

Activity Summary

IC50 1 meas. best 5.88

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Replicase polyprotein 1ab
CHEMBL4523582
IC50 5.88 5.88 1330.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Replicase polyprotein 1ab IC50 = 1330.0 nM 5.88 SARS-CoV-2 3CL-Pro protease inhibition IC50 determined by FRET kind of response ... -

Literature References

PubMed DOI Target Context # Activities
3712373 10.1021/jm00156a024 Mus musculus 5
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
18834112 10.1021/jm800656v Amine oxidase [flavin-containing] A 1
- 10.21203/rs.3.rs-23951/v1 SARS-CoV-2 1

Data from ChEMBL 36 via Core Engine